Results 51 to 60 of about 74,656 (168)

Gluten-Free hepatomiracle in “celiac hepatitis”: A case highlighting the rare occurrence of nutrition-induced near total reversal of advanced steatohepatitis and cirrhosis

The Saudi Journal of Gastroenterology, 2016
Regression of hepatic fibrosis is increasingly becoming a reality, both in clinical as well as experimental models. Reversal or near-total regression of marked liver steatohepatitis and fibrosis, however, remains a rare event.
Kavita Gaur, Puja Sakhuja, Amarender S Puri, Kaushik Majumdar   +3 more
doaj   +1 more source

Autologous Bone Marrow Stem Cell Transplantation in Liver Cirrhosis after Correcting Nutritional Anomalies, A Controlled Clinical Study

Cell Journal, 2019
Objective: Liver transplantation is the gold standard approach for decompensated liver cirrhosis. In recent years, stem cell therapy has raised hopes that adjusting some clinical and laboratory parameters could lead to successful treatments for this ...
Abbas Esmaeilzadeh, Homeira Ommati, Mohammad Mahdi Kooshyar, Lida Jarahi, Kambiz Akhavan Rezayat, Samaneh Saberi, Massoud Vosough, Ali Ghassemi   +7 more
doaj   +1 more source

An Experimental Inquiry into Cirrhosis of the Liver [PDF]

BMJ, 1898
V, Harley, W, Barratt
openaire   +2 more sources

Aluminum adjuvant promotes liver inflammation and fibrosis in mice: A novel approach to establish a liver fibrosis animal model

Liver Research
Background and aims: Liver fibrosis is a prevalent pathological stage of various chronic liver diseases and has the potential to progress to liver cirrhosis and hepatocellular carcinoma.
Zhixian Zhu, Sen Liang, Nan Zhao, Huiling Zou, Liangjun Zhang, Xiaoxun Zhang, Jin Chai   +6 more
doaj   +1 more source

LSECtin attenuates hepatic Th17 expansion in a murine model of cirrhosis and signals through the LAG-3 receptor

JHEP Reports
Background & Aims: LSECtin downregulation during cirrhosis progression is associated with adaptive T-cell expansion. We analyzed the molecular mechanism for LSECtin modulation of Th17 proliferation in an experimental cirrhosis model.
Sebastián Martínez-López, Oriol Juanola, Isabel Gómez-Hurtado, Enrique Ángel-Gomis, Paula Boix, Anabel Fernández-Iglesias, Alex Gallardo-Cruz, Francisco Javier Cubero, Jordi Gracia-Sancho, Amaya Puig-Kröger, Esther Caparrós, Rubén Francés   +11 more
doaj   +1 more source

Regression of fibrosis and portal hypertension in chronic liver disease: Endothelial perspectives and clinical implications

Annals of Hepatology
Chronic liver disease (CLD) remains a major global health burden, driven by persistent hepatic injury that triggers inflammation, vascular dysfunction and progressive extracellular matrix (ECM) deposition.
Yuly P Mendoza, Raül Pastó, Sonia E Selicean, Jordi Gracia-Sancho   +3 more
doaj   +1 more source

Acute HEV Infection Is a Relevant Cause of Decompensation and ACLF in Patients With Liver Cirrhosis. [PDF]

Liver Int
Dinkelborg K, Niehaus C, Bremer B, Wundes C, Tiede A, Petruch N, Deterding K, Kraft ARM, Hartleben B, Cornberg M, Wedemeyer H, Behrendt P, Maasoumy B.   +12 more
europepmc   +1 more source

The Gastrointestinal Barrier-Mechanisms of Barrier Dysfunction in Liver Cirrhosis and Spontaneous Bacterial Peritonitis. [PDF]

Biomedicines
Olaru-Stavila C, Steinmann SM, Mester P, Müller M, Tcaciuc E, Gülow K.   +5 more
europepmc   +1 more source

Epigenetic drug control of Clec4g/LSECtin expression reduces fibrosis burden in cirrhosis. [PDF]

Hepatol Commun
Ángel-Gomis E, Gómez-Hurtado I, Fernández-Barrena MG, Juanola O, Martínez-López S, Boix P, Ávila MA, Caparrós E, Francés R.   +8 more
europepmc   +1 more source

RETRACTION: "H-Ras Oncogene Expression and Angiogenesis in Experimental Liver Cirrhosis". [PDF]

Gastroenterol Res Pract
Practice GRA.
europepmc   +1 more source